Loading organizations...
§ Private Profile · Martinsried, Bayern, Germany
Biotechnology company pioneering treatments for autoimmune diseases.
SuppreMol has raised $20.4M across 1 funding round.
SuppreMol has raised $20.4M in total across 1 funding round.
SuppreMol has raised $20.4M in total across 1 funding round.
SuppreMol's investors include BioMedPartners, MIG Capital, Bayern Kapital, FCP Biotech Holding, KfW, Max Planck Society, Santo Holding.
SuppreMol has raised $20.4M across 1 funding round. Most recently, it raised $20.4M Series C in December 2010.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 17, 2010 | $20.4M Series C | BioMedPartners, MIG Capital | Bayern Kapital, FCP Biotech Holding, KFW, MAX Planck Society, Santo Holding | Announced |